Search Results 81-90 of 8422 for TNF
Participation eligibility · TNF inhibitors (adalimumab, certolizumab, etanercept, golimumab, or infliximab) · Abatacept (Orencia; IV or SC) · Tocilizumab (Actemra; ...
... TNF alpha agents. A Study to Establish and Validate Standard Operating Procedures for Laboratory Tests on Synovial Fluid Rochester, MN. The purpose of this ...
TNF-inhibitors; Methotrexate; IL-1Ra antagonist. Women who are pregnant or nursing; Elect not to provide peripheral blood draw. Cohort 2: History of ipsilateral ...
... TNF-α apoptotic pathway, 2)alternative splicing, tipping the balance towards pro-apoptotic as opposed to anti-apoptotic isoforms, and 3)inhibition of the ...
People with certain autoimmune diseases, such as rheumatoid arthritis or Crohn's disease, who are being treated with anti-tumor necrosis factor (TNF) drugs also ...
... TNF alpha agents. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
... tumor necrosis factor receptor antagonist in adults with a clinical diagnosis of rheumatoid arthritis. Participation eligibility. Participant eligibility ...
Accelerating Earlier Access to Anti-TNF-alpha Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease. J Clin Med. 2025 Feb 26; 14 ...
Anti-TNF monotherapy;; anti-TNF combination therapy;; tofacitinib;; current use of systemic corticosteroids. Exclusion Criteria: Previously received COVID 19 ...
Is naïve to biologic therapy (TNF antagonists or vedolizumab); Has received biologic therapy but has not demonstrated a history of failure to respond to, or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.